MORE INFORMATION
NOTES
GLOSSARY
Castration-resistant (CR): Prostate cancer that keeps growing even when the amount of testosterone in the body is reduced to very low levels. Hormone therapy: Includes gonadotropin-releasing hormone (GnRH), such as Lupron Depot ® (drug treatment), or surgery that lowers testosterone. Metastasis: The spread of cancer to other parts of the body. Metastasis-free survival (MFS): A term used to define how long a man lives before his prostate cancer spreads to other parts of his body. Overall survival (OS): How long a person may live after starting therapy. Prostate-specific antigen (PSA): PSA is a protein found in the blood. It is used to track changes in prostate cancer. Testosterone: Called the “male hormone,” it is an androgen-type hormone that causes men’s secondary sexual characteristics to develop. In men with prostate cancer, testosterone can also cause the cancer to grow and spread.
TAKE TIME TO ENJOY THE LITTLE THINGS. advice from a prostate cancer patient
IMPORTANT SAFETY INFORMATION (continued) NUBEQA may cause serious side effects, including (continued): • Seizure. Treatment with NUBEQA may increase your risk of having a seizure. You should avoid activities where a sudden loss of consciousness could cause serious harm to yourself or others. Tell your healthcare provider right away if you have loss of consciousness or seizure The most common side effects of NUBEQA in people with nmCRPC include:
IT’S IMPORTANT TO STAY POSITIVE. advice from a caregiver
• increase in liver function tests • decreased white blood cells (neutropenia)
• feeling more tired than usual • arm, leg, hand, or foot pain • rash
Please see additional Important Safety Information throughout and the full Prescribing Information.
23
Made with FlippingBook flipbook maker